<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0045503</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1920</journal-id>
<journal-id journal-id-type="nlm-ta">Brain Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Res.</journal-id>
<journal-title-group>
<journal-title>Brain research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8993</issn>
<issn pub-type="epub">1872-6240</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26778174</article-id>
<article-id pub-id-type="pmc">4939136</article-id>
<article-id pub-id-type="doi">10.1016/j.brainres.2015.12.051</article-id>
<article-id pub-id-type="manuscript">NIHMS765160</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glia - Neuron Interactions in Neurological Diseases: Testing Non-cell Autonomy in a Dish</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Meyer</surname>
<given-names>Kathrin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaspar</surname>
<given-names>Brian K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, USA</aff>
<aff id="A2"><label>2</label>Molecular, Cellular &amp; Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio, USA</aff>
<aff id="A3"><label>3</label>Department of Neuroscience, The Ohio State University, Columbus, Ohio, USA</aff>
<author-notes>
<corresp id="FN1">Address Correspondence to: Brian K. Kaspar, Ph.D., The Research Institute at Nationwide Children’s Hospital, 700 Children’s Drive WA 3022, Columbus, OH 43205, (Ph) 614.722.5085 (Fax) 614.355.5247, <email>Brian.Kaspar@NationwideChildrens.org</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>1656</volume>
<fpage>27</fpage>
<lpage>39</lpage>
<!--elocation-id from pubmed: 10.1016/j.brainres.2015.12.051-->
<abstract>
<p id="P2">For the past century, research on neurological disorders has largely focused on the most prominently affected cell types – the neurons. However, with increasing knowledge of the diverse physiological functions of glial cells, their impact on these diseases has become more evident. Thus, many conditions appear to have more complex origins than initially thought.</p>
<p id="P3">Since neurological pathologies are often sporadic with unknown etiology, animal models are difficult to create and might only reflect a small portion of patients in which a mutation in a gene has been identified. Therefore, reliable <italic>in vitro</italic> systems to studying these disorders are urgently needed. They might be a pre-requisite for improving our understanding of the disease mechanisms as well as for the development of potential new therapies. In this review, we will briefly summarize the function of different glial cell types in the healthy central nervous system (CNS) and outline their implication in the development or progression of neurological conditions. We will then describe different types of culture systems to model non-cell autonomous interactions <italic>in vitro</italic> and evaluate advantages and disadvantages.</p>
</abstract>
<kwd-group>
<kwd>Direct Conversion</kwd>
<kwd>Induced Pluripotent Stem Cells</kwd>
<kwd>Neurodegeneration</kwd>
<kwd>Non-cell Autonomy</kwd>
<kwd><italic>In Vitro</italic> Systems</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>